Vital Farms Q3 2026 Earnings: Egg Oversupply Compresses Margins
Vital Farms reported fiscal Q3 2026 net revenue of $182.2 million, down 8.4% year-over-year, with diluted EPS swinging to a loss of $0.15. Gross margin fell sharply to 23.1% due to higher production costs and an unfavorable channel mix from excess egg supply. Operating and net losses were recorded, alongside negative operating cash flow for the first 39 weeks. Management lowered full-year guidance, now expecting a net revenue of around $730 million and an adjusted EBITDA loss, while withdrawing 2030 financial targets. Key risks include persistent supply pressures, slower distribution velocity, and execution uncertainties surrounding the projected Q4 recovery.
Vital Farms (NASDAQ: VITL) reported fiscal Q3 2026 net revenue of $182.2 million, down 8.4% from $198.9 million a year earlier, while diluted EPS swung to a loss of $0.15 from income of $0.36 per share. Gross margin fell sharply as higher input and production costs combined with an unfavorable channel mix caused by excess egg supply. Even so, revenue rose 9.7% sequentially and adjusted EBITDA improved by $28.1 million from Q2.
Core Financial Results
The year-over-year revenue decline reflected a $14.3 million price/mix reduction and a $2.2 million volume decline outside the breaker and wholesale channels. Retail-channel revenue decreased to $175.1 million from $189.7 million.
Profitability deteriorated more substantially than revenue. Gross profit declined by about 44%, adjusted EBITDA fell to $1.5 million, and the company recorded operating and net losses.
| Metric | Q3 2026 | Q3 2025 | Year-over-Year Change |
|---|---|---|---|
| Net revenue | $182.2 million | $198.9 million | -8.4% |
| Retail-channel revenue | $175.1 million | $189.7 million | About -7.7% |
| Gross profit | $42.1 million | $75.0 million | About -43.8% |
| Gross margin | 23.1% | 37.7% | -14.6 percentage points |
| Operating income (loss) | $(7.7) million | $21.4 million | Swung to a loss |
| Net income (loss) | $(6.5) million | $16.4 million | Swung to a loss |
| Diluted EPS | $(0.15) | $0.36 | Swung to a loss |
| Adjusted EBITDA | $1.5 million | $27.4 million | About -94.5% |
Egg Oversupply Shifted Sales Into Lower-Priced Channels
Vital Farms’ excess egg inventory led to higher sales through breaker and wholesale channels, where pricing was lower. Although volume in these channels increased substantially, the price decline more than offset that increase and contributed $0.3 million to the overall revenue decline.
The unfavorable mix reduced gross profit by $7.9 million. Combined with higher input and production costs, it was the central reason gross margin fell from 37.7% to 23.1% and adjusted EBITDA declined from $27.4 million to $1.5 million.
The company nevertheless expanded distribution and reached record dollar and volume share in the shell egg category. Some new placements reached shelves later than planned, however, and management is using a more conservative assumption for their near-term sales velocity. That timing and velocity gap helps explain why distribution gains did not translate into stronger year-over-year revenue during the quarter.
Profitability, Cash Flow, and the Balance Sheet
Total operating expenses declined to $49.8 million from $53.6 million, providing only a partial offset to the $32.8 million reduction in gross profit. Selling, general and administrative expense fell to $38.1 million from $44.4 million under tighter spending controls, while shipping and distribution expense increased to $11.7 million from $9.2 million. Operating margin was approximately negative 4.2%, compared with positive 10.8% a year earlier.
The net loss also reflected higher interest expense of $2.9 million, up from $0.2 million. Lower SG&A expense and a $2.8 million income tax benefit reduced some of the pressure but did not offset the decline in gross profit.
Cash-flow figures cover the first 39 weeks of fiscal 2026 rather than Q3 alone. Operating activities used $54.4 million during that period, compared with $27.9 million of cash generated in the comparable period of fiscal 2025. Capital expenditures rose to $51.7 million from $44.0 million.
Vital Farms ended September 27 with $84.0 million in cash and cash equivalents and $117.6 million of outstanding debt. Inventory declined to $50.3 million from $66.5 million at the end of fiscal 2025, consistent with the company’s efforts to reduce excess supply. The higher cash balance occurred alongside new borrowing, while financing activities also included $35.0 million of share repurchases during the first 39 weeks.
Fiscal 2026 Guidance
Vital Farms lowered its full-year revenue outlook and changed its adjusted EBITDA forecast from a profit to a loss. Management attributed the revision to later-than-expected distribution placements, more conservative assumptions for their near-term velocity, and the absence of assumed seasonal improvement in demand or conventional egg pricing.
| Metric | Latest Fiscal 2026 Guidance | Previous Guidance | Change |
|---|---|---|---|
| Net revenue | Around $730 million | $775 million-$800 million | Lowered |
| Adjusted EBITDA | Loss of around $15 million | Gain of $0-$10 million | Reduced to a loss |
| Capital expenditures | $70 million-$75 million | $70 million-$75 million | Reaffirmed |
Management still expects Q4 to improve sequentially from Q3, supported by lower anticipated breaker and supply-management costs, recent distribution gains, and structural cost actions. This expected improvement was not quantified.
Vital Farms also withdrew its previously announced fiscal 2030 financial targets. The company plans to revisit long-term targets after making more progress on margin expansion and profitability, leaving investors without the prior long-range framework in the meantime.
Recent Insider Transactions
The detailed insider transaction data included three reported purchases in May 2026 and seven zero-price director stock awards on June 10, 2026. The purchases are listed below without interpreting them as an indication of management’s outlook.
| Date | Insider | Role | Transaction | Price per Share | Disclosed Value |
|---|---|---|---|---|---|
| May 19, 2026 | Reena Chauhan Van Hoven | Officer | Purchase | $8.92 | $19,999 |
| May 18, 2026 | Glenda J. Flanagan | Director | Purchase | $8.33 | $50,813 |
| May 18, 2026 | Glenda J. Flanagan | Director | Purchase | $8.33 | $50,813 |
A separate six-month insider summary reported zero purchases despite these detailed entries, indicating a discrepancy between the summary and transaction-level data.
Risks Investors Need to Watch
- Persistent supply and mix pressure: Continued excess egg supply could require more sales through lower-priced breaker and wholesale channels, weighing on revenue quality and gross margin.
- Distribution velocity: New retail placements arrived later than expected, and management has reduced its assumptions for near-term sales velocity. Slow sell-through could limit the benefit of wider distribution.
- Cost and cash-flow pressure: Higher input and production expenses contributed to the quarterly loss, while operating activities used $54.4 million over the first 39 weeks and capital spending remained elevated.
- Execution of the Q4 recovery: The expected sequential improvement depends on lower supply-management costs, distribution gains, and cost actions. The fiscal 2026 guidance reduction and withdrawal of the 2030 targets indicate that sustained improvement has not yet been demonstrated.
Summary
Vital Farms’ third quarter improved from a difficult Q2 but remained substantially weaker than the prior-year period. Excess supply, lower-priced channel sales, and higher production costs compressed gross margin and pushed the company into a net loss, while delayed distribution placements limited revenue growth. The central issues ahead are whether inventory and breaker-channel costs continue to decline, whether new distribution generates stronger velocity, and whether the expected Q4 improvement can begin restoring profitability and cash generation.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles










Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.